Jaguar Health, Inc. (JAGX)
NASDAQ: JAGX · Real-Time Price · USD
1.240
-0.110 (-8.15%)
At close: Nov 20, 2025, 4:00 PM EST
1.300
+0.060 (4.84%)
After-hours: Nov 20, 2025, 6:32 PM EST
Jaguar Health Market Cap
Jaguar Health has a market cap or net worth of $4.63 million as of November 20, 2025. Its market cap has decreased by -51.80% in one year.
Market Cap
4.63M
Enterprise Value
33.42M
1-Year Change
-51.80%
Ranking
Category
Stock Price
$1.24
Market Cap Chart
Since October 5, 2018, Jaguar Health's market cap has decreased from $13.36M to $4.63M, a decrease of -65.32%. That is a compound annual growth rate of -13.80%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 19, 2025 | 5.04M | -57.68% |
| Dec 31, 2024 | 11.92M | 55.07% |
| Dec 29, 2023 | 7.68M | -41.52% |
| Dec 30, 2022 | 13.14M | -72.54% |
| Dec 31, 2021 | 47.85M | -44.06% |
| Dec 31, 2020 | 85.54M | 619.17% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Oct 5, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 922.29B |
| Johnson & Johnson | 481.86B |
| AbbVie | 413.34B |
| UnitedHealth Group | 284.05B |
| AstraZeneca | 276.37B |
| Novartis AG | 244.75B |
| Merck & Co. | 239.34B |
| Abbott Laboratories | 226.05B |